EUVIMEDEUVIMED entdecken
Multizentrische Studie

A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis

Giulia Bandini iD, Alessia Alunno iD, Filipe O Pinheiro, Corrado Campochiaro iD, Ilaria Galetti, Pietro Matucci-Cerinic, Barbara Ruaro iD, Khadija El Aoufy iD, Maria R Melis, Alberto Moggi Pignone, Silvia Bellando Randone, Lorenzo Dagna und 3 weitere

Arthritis Care & Research · 2024

DOI: 10.1002/acr.25280 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Arthritis Care & Research, 2024. Verfasst von Giulia Bandini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Division of Internal Medicine, University of Florence, AOUC, Florence, Italy. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Scleroderma, Systemic, Gastroesophageal Reflux, Needs Assessment. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: World Scleroderma Foundation (WSF) Gastrointestinal ad hoc committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Proton pump inhibitors (PPIs) are widely prescribed to treat gastroesophageal reflux disease (GERD) in Systemic Sclerosis (SSc). However, not all patients adequately respond to the treatment, and there are frequent concerns about the safety of long‐term use of PPIs. Our aim was to identify the main problems/complaints of SSc patients on PPIs, as well as understand their unmet needs.

Methods

SSc patients treated with PPIs were invited through international patient associations and social media to participate in an online survey.

Results

We gathered 301 valid responses from 14 countries (United Kingdom 19.3% and United States 70.4%). Multiple PPIs use (two: 30% and three: 21% in series) was common. The majority (89%) reported improvement in gastrointestinal symptoms from receiving PPIs. Side effects attributed to receiving PPIs were uncommon (19%); however, most (79%) were potentially concerned. Around half (58%) had received lifestyle information, and most (85%) had searched online for information about PPIs. Only in the minority (12%) had a surgical approach been discussed; however, half (46%) indicated that they would be willing to undergo surgery to resolve their GERD symptoms but had important concerns.

Conclusion

Despite the frequent use of PPIs in patients with SSc, there is significant heterogeneity in prescription, and combination therapy (PPIs plus other medication for acid reflux) is not uncommon (approximately 40%). Patients have significant concerns about PPIs side effects. Education about PPIs is often neglected, and patients very frequently use online sources to obtain information on drug treatment. A surgical approach is infrequently discussed, and patients fear this potential therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsScleroderma, SystemicGastroesophageal RefluxNeeds AssessmentHealth Services Needs and DemandHumansFemaleMaleMiddle AgedAgedAdultSurveys and QuestionnairesUnited States

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, Division of Internal Medicine, University of Florence, AOUC, Florence, Italy.
  • Department of Clinical Medicine, Life Health and Environmental Sciences, Internal Medicine and Nephrology Division, University of L'Aquila, L'Aquila, Italy.
  • Department of Rheumatology, Centro Hospitalar Universitário de São João, Porto, Portugal.
  • Unit of Immunology, Rheumatology, Allergy and Rare diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy.
  • FESCA (Federation of European Scleroderma Associations), Belgium, and GILS (Gruppo Italiano Lotta alla Sclerodermia), Milan, Italy.
  • Department of Surgery, Division of Surgery and Transplantation, University of Udine, Udine, Italy.

ORCID-Profile: Giulia Bandini, Alessia Alunno, Corrado Campochiaro, Barbara Ruaro, Khadija El Aoufy, Zsuzsanna H McMahan, Michael Hughes

Förderung

  • World Scleroderma Foundation (WSF) Gastrointestinal ad hoc committee

Zitieren

APA

Bandini, G., Alunno, A., Pinheiro, F. O., Campochiaro, C., Galetti, I., Matucci-Cerinic, P., Ruaro, B., El Aoufy, K., Melis, M. R., Pignone, A. M., Randone, S. B., Dagna, L., Matucci-Cerinic, M., McMahan, Z. H., & Hughes, M. (2024). A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis. Arthritis Care & Research. https://doi.org/10.1002/acr.25280

Vancouver

Bandini G, Alunno A, Pinheiro FO, Campochiaro C, Galetti I, Matucci-Cerinic P, et al. A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis. Arthritis Care & Research. 2024. doi:10.1002/acr.25280

BibTeX
@article{Bandini2024,
  author = {Bandini, Giulia and Alunno, Alessia and Pinheiro, Filipe O and Campochiaro, Corrado and Galetti, Ilaria and Matucci-Cerinic, Pietro and Ruaro, Barbara and El Aoufy, Khadija and Melis, Maria R and Pignone, Alberto Moggi and Randone, Silvia Bellando and Dagna, Lorenzo and Matucci-Cerinic, Marco and McMahan, Zsuzsanna H and Hughes, Michael},
  title = {A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis},
  journal = {Arthritis Care & Research},
  year = {2024},
  doi = {10.1002/acr.25280}
}
Kostenlos starten →